P2Y2 purinoreceptor agonists (Celltech)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameP2Y2 purinoreceptor agonists (Celltech)
Drug Alias Nameuridine triphosphate mimetics (Celltech)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic receptor P2Y2 agonists
TargetsPurinergic receptor P2Y2
Therapy Area/IndicationsIschemiaLung Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUcb Celltech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUcb Celltech
Active IndicationsN/A
Inactive IndicationsIschemiaLung Diseases

Other Information

ATC CodeN/A
Related LinksN/A